Results 291 to 300 of about 69,255 (333)

Pretransplant NT-proBNP levels are associated with mortality among lung transplant recipients. [PDF]

Pulm Circ
Izhakian S, Frajman A, Hayat AD, Gorenshtein A, Shtraichman O, Freidkin L, Rosengarten D, Kramer MR.   +7 more
europepmc   +1 more source

Erratum: Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study [Corrigendum]. [PDF]

Neuropsychiatr Dis Treat
europepmc   +1 more source

Reservoir-excess pressure parameters are independently associated with NT-proBNP in older adults. [PDF]

ESC Heart Fail
Aizawa K, Hughes AD, Casanova F, Gooding KM, Gates PE, Mawson DM, Williams J, Goncalves I, Nilsson J, Khan F, Colhoun HM, Palombo C, Parker KH, Shore AC.   +13 more
europepmc   +1 more source

Association of baseline and longitudinal changes in insulin‐like growth factor‐binding protein‐7 with the risk of incident heart failure: Data from the PREVEND study

European Journal of Heart Failure, EarlyView.
Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.
Sabrina Abou Kamar, Valentina Bracun, Maissa El‐Qendouci, Nils Bomer, Stephan J.L. Bakker, Ron T. Gansevoort, Eric Boersma, Isabella Kardys, Rudolf A. de Boer, Navin Suthahar   +9 more
wiley   +1 more source

Exploring the Relationship Between Ejection Fraction, Arterial Stiffness, NT-proBNP, and Hospitalization Risk in Heart Failure Patients. [PDF]

Diagnostics (Basel)
Osser G, Osser B, Toth C, Miuța CC, Marconi GR, Bondar LI.   +5 more
europepmc   +1 more source

The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.
Giovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, Vincenzo Castiglione, Marianna Adamo, Iacopo Fabiani, Victor Loghin, Carlo Mario Lombardi, Alessio Nicolai, Marco Metra, Michele Emdin, Alberto Aimo   +11 more
wiley   +1 more source

Microvascular obstruction in cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Abstract Aims Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the prevalence of microvascular obstruction (MVO) in patients with CA and to assess the association between MVO and prognosis ...
Lucrezia Netti, Adam Ioannou, Ana Martinez‐Naharro, Yousuf Razvi, Aldostefano Porcari, Lucia Venneri, Viviana Maestrini, Dan Knight, Ruta Virsinskaite, Muhammad U. Rauf, Tushar Kotecha, Rishi K. Patel, Ashutosh Wechelakar, Helen Lachmann, Peter Kellman, Charlotte Manisty, James Moon, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana   +19 more
wiley   +1 more source

NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank. [PDF]

Diabetologia
Ma RCW, Tam CHT, Hou Y, Lau ESH, Ozaki R, Lui JNM, Chow E, Kong APS, Huang C, Ng ACW, Fung EG, Luk AOY, So WY, Lim CKP, Chan JCN, Hong Kong Diabetes Biobank Study Group.   +15 more
europepmc   +1 more source

Association of microRNA-210-3p with NT-proBNP, sST2, and Galectin-3 in heart failure patients with preserved and reduced ejection fraction: A cross-sectional study. [PDF]

PLoS One
Arul JC, Raja Beem SS, Parthasarathy M, Kuppusamy MK, Rajamani K, Silambanan S.   +5 more
europepmc   +1 more source